Pharmacokinetics of Piroxicam Pharmaceutical Forms: An Experimental Study

Q3 Pharmacology, Toxicology and Pharmaceutics
I. Men'shikova, O. V. Zakharova
{"title":"Pharmacokinetics of Piroxicam Pharmaceutical Forms: An Experimental Study","authors":"I. Men'shikova, O. V. Zakharova","doi":"10.5530/CTBP.2021.2.18","DOIUrl":null,"url":null,"abstract":"Research into new ways to administer medications within the body remains relevant. The study aims to analyze the particularities of piroxicam kinetics in zein-pectin complexes during ex vivo experiments in a medium simulating the gastrointestinal tract of laboratory rats. Studies were performed in 2019 with 30 laboratory Wistar rats. During 3 days, rats received 2.5 ml of 2% pectin solution per day. The ratio between pectin and zein was 3:1. Rats were mortified, and their intestines were then dissected into 3-cm fragments. The obtained samples were placed in containers with 5 ml of saline phosphate buffer solution (solution pH = 6.4). Gastrointestinal contents and pectin apple and citrus complexes with low methylation were incubated to study the kinetics of piroxicam. Pectin complexes varied in dry carrier mass: the citrus complex was 1.3 times greater than the apple complex (pd”0.05). It was also observed that the release time of 50% of the volume of piroxicam was 1.3 times faster for the citrus complex (pd”0.05) than for the apple complex. In terms of swelling index, citrus complexes were 1.9 times larger than apple complexes (pd”0.01). Citrus complexes contained a lower concentration of piroxicam (1.3 times, pd”0.05) relative to apple complexes. The longterm effect of piroxicam release from pectin complexes was established during the experiment. This is likely due to the slow swelling of the ion part of the polymer mesh under hydrophobic solution conditions. The latter was represented in the experiment by the phosphate buffer and the content of the gastrointestinal tract. The limiting factor that influenced the release kinetics of piroxicam from pectin complexes is its diffusion process from the pectin complex. A high correlation was observed between the 50% piroxicam release and the square root of time in both complexes (0.98). Apple pectin was 3.0 times larger than the constant (p d”0.01). The kinetics analysis demonstrated their linear directionality over approximately 40 hours.","PeriodicalId":10980,"journal":{"name":"Current Trends in Biotechnology and Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Trends in Biotechnology and Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5530/CTBP.2021.2.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Research into new ways to administer medications within the body remains relevant. The study aims to analyze the particularities of piroxicam kinetics in zein-pectin complexes during ex vivo experiments in a medium simulating the gastrointestinal tract of laboratory rats. Studies were performed in 2019 with 30 laboratory Wistar rats. During 3 days, rats received 2.5 ml of 2% pectin solution per day. The ratio between pectin and zein was 3:1. Rats were mortified, and their intestines were then dissected into 3-cm fragments. The obtained samples were placed in containers with 5 ml of saline phosphate buffer solution (solution pH = 6.4). Gastrointestinal contents and pectin apple and citrus complexes with low methylation were incubated to study the kinetics of piroxicam. Pectin complexes varied in dry carrier mass: the citrus complex was 1.3 times greater than the apple complex (pd”0.05). It was also observed that the release time of 50% of the volume of piroxicam was 1.3 times faster for the citrus complex (pd”0.05) than for the apple complex. In terms of swelling index, citrus complexes were 1.9 times larger than apple complexes (pd”0.01). Citrus complexes contained a lower concentration of piroxicam (1.3 times, pd”0.05) relative to apple complexes. The longterm effect of piroxicam release from pectin complexes was established during the experiment. This is likely due to the slow swelling of the ion part of the polymer mesh under hydrophobic solution conditions. The latter was represented in the experiment by the phosphate buffer and the content of the gastrointestinal tract. The limiting factor that influenced the release kinetics of piroxicam from pectin complexes is its diffusion process from the pectin complex. A high correlation was observed between the 50% piroxicam release and the square root of time in both complexes (0.98). Apple pectin was 3.0 times larger than the constant (p d”0.01). The kinetics analysis demonstrated their linear directionality over approximately 40 hours.
吡罗昔康剂型的药代动力学实验研究
研究在体内给药的新方法仍然很有意义。本研究旨在分析玉米醇溶蛋白-果胶复合物在模拟实验大鼠胃肠道的离体实验中吡罗昔康动力学的特殊性。2019年对30只实验室Wistar大鼠进行了研究。在3天内,大鼠每天接受2.5毫升2%果胶溶液。果胶与玉米醇溶蛋白的比例为3:1。将大鼠处死,然后将它们的肠道解剖成3厘米的碎片。将获得的样品放入装有5ml磷酸盐水缓冲溶液(溶液pH=6.4)的容器中。培养胃肠道内容物和低甲基化的果胶-苹果和柑橘复合物,以研究吡罗昔康的动力学。果胶复合物的干载体质量各不相同:柑橘复合物是苹果复合物的1.3倍(pd“0.05)。还观察到,50%体积的吡罗昔康的释放时间柑橘复合物(pd”0.05)比苹果复合物快1.3倍。就溶胀指数而言,柑橘复合物是苹果复合物的1.9倍(pd“0.01)。柑橘复合物中吡罗昔康的浓度比苹果复合物低(1.3倍,pd”0.05)。在实验过程中确定了吡罗昔康从果胶复合物中释放的长期效应。这可能是由于聚合物网的离子部分在疏水溶液条件下缓慢溶胀。后者在实验中用磷酸盐缓冲液和胃肠道的含量来表示。影响吡罗昔康从果胶络合物中释放动力学的限制因素是其从果胶络合物的扩散过程。在两种复合物中,50%吡罗昔康的释放量与时间的平方根之间存在高度相关性(0.98)。苹果果胶比常数大3.0倍(p d“0.01)。动力学分析表明,它们在大约40小时内具有线性方向性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Trends in Biotechnology and Pharmacy
Current Trends in Biotechnology and Pharmacy Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
0.70
自引率
0.00%
发文量
0
期刊介绍: The Association of Biotechnology and Pharmacy (ABAP) will be useful to form a forum for scientists so that they can bring together to discuss and find scientific solutions to the problems of society. The annual meetings will help the members to share their knowledge and publish their research knowledge particularly by members and fellows of the Association and special care will be taken to provide an opportunity for young scientists. Besides this the association is planned to organize symposia, seminars and workshops on current developments of Biotechnology and Pharmacy particularly on the subject of current scientific interest, and the proceedings of which will be published regularly. And in view of the vast development of science and to disseminate the problems in publication of research work, an international journal of Current Trends in Biotechnology and Pharmacy has been started by ABAP.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信